IL-8 -251A/T polymorphism is associated with decreased cancer risk among population-based studies: Evidence from a meta-analysis

European Journal of Cancer

Volumn 46, Issue 8, 2010, Pages 1333-1343

  Gao, Lin Bo ^a   Pan, Xin Min ^b,c   Jia, Jing ^d   Liang, Wei Bo ^b   Rao, Li ^e   Xue, Hui ^b   Zhu, Yi ^b   Li, Shi Liu ^b   Lv, Mei Li ^b   Deng, Wei ^b   Chen, Tian Yi ^b   Wei, Yong Gang ^e   Zhang, Lin ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

^c HENAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^d INSTITUTE OF MATERIA MEDICA   (China)

^e SICHUAN UNIVERSITY   (China)

Author keywords

Cancer; Interleukin 8; Meta analysis; Single nucleotide polymorphism

Indexed keywords

ADENOSINE; INTERLEUKIN 8; THYMIDINE;

ARTICLE; BASAL CELL CARCINOMA; BLADDER CANCER; BREAST CARCINOMA; CANCER GENETICS; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; COLORECTAL CANCER; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ETHNICITY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HIGH RISK POPULATION; HUMAN; LUNG NON SMALL CELL CANCER; MELANOMA; NASOPHARYNX CARCINOMA; POPULATION RESEARCH; PRIORITY JOURNAL; PROSTATE CANCER; RISK REDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH CANCER; FEMALE; GENETIC PREDISPOSITION; GENETICS; MALE; META ANALYSIS; METABOLISM; NEOPLASM; RISK; RISK FACTOR;

FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-8; MALE; NEOPLASMS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 77951667554     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2010.03.011     Document Type: Article

References (67)

1. Hull J., Ackerman H., Isles K., et al. Unusual haplotypic structure of IL8, a susceptibility locus for a common respiratory virus. Am J Hum Genet 69 (2001) 413-419
2. Matsushima K., and Oppenheim J.J. Interleukin 8 and MCAF: novel inflammatory cytokines inducible by IL 1 and TNF. Cytokine 1 (1989) 2-13
3. Baggiolini M., Walz A., and Kunkel S.L. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest 84 (1989) 1045-1049
4. Harada A., Sekido N., Akahoshi T., et al. Essential involvement of interleukin-8 (IL-8) in acute inflammation. J Leukoc Biol 56 (1994) 559-564
5. Wang Y., Yang J., Gao Y., et al. Regulatory effect of e2, IL-6 and IL-8 on the growth of epithelial ovarian cancer cells. Cell Mol Immunol 2 (2005) 365-372
6. Mizukami Y., Jo W.S., Duerr E.M., et al. Induction of interleukin-8 preserves the angiogenic response in HIF-1alpha-deficient colon cancer cells. Nat Med 11 (2005) 992-997
7. Boldrini L., Gisfredi S., Ursino S., et al. Interleukin-8 in non-small cell lung carcinoma: relation with angiogenic pattern and p53 alterations. Lung Cancer 50 (2005) 309-317
8. Zhang W., Stoehlmacher J., Park D.J., et al. Gene polymorphisms of epidermal growth factor receptor and its downstream effector, interleukin-8, predict oxaliplatin efficacy in patients with advanced colorectal cancer. Clin Colorectal Cancer 5 (2005) 124-131
9. Itoh Y., Joh T., Tanida S., et al. IL-8 promotes cell proliferation and migration through metalloproteinase-cleavage proHB-EGF in human colon carcinoma cells. Cytokine 29 (2005) 275-282
10. Mukaida N., Shiroo M., and Matsushima K. Genomic structure of the human monocyte-derived neutrophil chemotactic factor IL-8. J Immunol 143 (1989) 1366-1371
11. Hull J., Thomson A., and Kwiatkowski D. Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families. Thorax 55 (2000) 1023-1027
12. Taguchi A., Ohmiya N., Shirai K., et al. Interleukin-8 promoter polymorphism increases the risk of atrophic gastritis and gastric cancer in Japan. Cancer Epidemiol Biomarkers Prev 14 (2005) 2487-2493
13. Ohyauchi M., Imatani A., Yonechi M., et al. The polymorphism interleukin 8 -251 A/T influences the susceptibility of Helicobacter pylori related gastric diseases in the Japanese population. Gut 54 (2005) 330-335
14. Ye B.D., Kim S.G., Park J.H., et al. The interleukin-8 -251 A allele is associated with increased risk of noncardia gastric adenocarcinoma in Helicobacter pylori-infected Koreans. J Clin Gastroenterol 43 (2009) 233-239
15. Lee W.P., Tai D.I., Lan K.H., et al. The -251T allele of the interleukin-8 promoter is associated with increased risk of gastric carcinoma featuring diffuse-type histopathology in Chinese population. Clin Cancer Res 11 (2005) 6431-6441
16. Canedo P., Castanheira-Vale A.J., Lunet N., et al. The interleukin-8 -251*T/*A polymorphism is not associated with risk for gastric carcinoma development in a Portuguese population. Eur J Cancer Prev 17 (2008) 28-32
17. Crusius J.B., Canzian F., Capella G., et al. Cytokine gene polymorphisms and the risk of adenocarcinoma of the stomach in the European prospective investigation into cancer and nutrition (EPIC-EURGAST). Ann Oncol 19 (2008) 1894-1902
18. Garza-Gonzalez E., Bosques-Padilla F.J., Mendoza-Ibarra S.I., et al. Assessment of the toll-like receptor 4 Asp299Gly, Thr399Ile and interleukin-8-251 polymorphisms in the risk for the development of distal gastric cancer. BMC Cancer 7 (2007) 70
19. Kamangar F., Abnet C.C., Hutchinson A.A., et al. Polymorphisms in inflammation-related genes and risk of gastric cancer (Finland). Cancer Causes Control 17 (2006) 117-125
20. Kang JM, Kim N, Lee DH, et al. The effects of genetic polymorphisms of IL-6, IL-8, and IL-10 on Helicobacter pylori-induced gastroduodenal diseases in Korea. J Clin Gastroenterol 2008.
21. Ko K.P., Park S.K., Cho L.Y., et al. Soybean product intake modifies the association between interleukin-10 genetic polymorphisms and gastric cancer risk. J Nutr 139 (2009) 1008-1012
22. Lu W., Pan K., Zhang L., et al. Genetic polymorphisms of interleukin (IL)-1B, IL-1RN, IL-8, IL-10 and tumor necrosis factor alpha and risk of gastric cancer in a Chinese population. Carcinogenesis 26 (2005) 631-636
23. Savage S.A., Hou L., Lissowska J., et al. Interleukin-8 polymorphisms are not associated with gastric cancer risk in a Polish population. Cancer Epidemiol Biomarkers Prev 15 (2006) 589-591
24. Shirai K., Ohmiya N., Taguchi A., et al. Interleukin-8 gene polymorphism associated with susceptibility to non-cardia gastric carcinoma with microsatellite instability. J Gastroenterol Hepatol 21 (2006) 1129-1135
25. Zeng Z.R., Zhou S.Z., Liao S.Y., et al. Correlation of polymorphism of interleukin 8 gene-251 locus and gastric cancer in high and low prevalence regions in china. J Sun Yat-sen Univ (Med Sci) 26 (2005) 537-540
26. Savage S.A., Abnet C.C., Mark S.D., et al. Variants of the IL8 and IL8RB genes and risk for gastric cardia adenocarcinoma and esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 13 (2004) 2251-2257
27. Kamali-Sarvestani E., Aliparasti M.R., and Atefi S. Association of interleukin-8 (IL-8 or CXCL8) -251T/A and CXCR2 +1208C/T gene polymorphisms with breast cancer. Neoplasma 54 (2007) 484-489
28. Liu J.Y., Zhai X.J., Jin G.F., et al. A study of relationship between polymorphisms of interleukin-8 and risk of breast cancer in Chinese population. China Cancer 16 (2007) 8-10
29. Smith K.C., Bateman A.C., Fussell H.M., and Howell W.M. Cytokine gene polymorphisms and breast cancer susceptibility and prognosis. Eur J Immunogenet 31 (2004) 167-173
30. Snoussi K., Mahfoudh W., Bouaouina N., et al. Genetic variation in IL-8 associated with increased risk and poor prognosis of breast carcinoma. Hum Immunol 67 (2006) 13-21
31. Vogel U., Christensen J., Nexo B.A., et al. Peroxisome proliferator-activated [corrected] receptor-gamma2 [corrected] Pro12Ala, interaction with alcohol intake and NSAID use, in relation to risk of breast cancer in a prospective study of Danes. Carcinogenesis 28 (2007) 427-434
32. Kury S., Buecher B., Robiou-du-Pont S., et al. Low-penetrance alleles predisposing to sporadic colorectal cancers: a French case-controlled genetic association study. BMC Cancer 8 (2008) 326
33. Landi S., Moreno V., Gioia-Patricola L., et al. Association of common polymorphisms in inflammatory genes interleukin (IL)6, IL8, tumor necrosis factor alpha, NFKB1, and peroxisome proliferator-activated receptor gamma with colorectal cancer. Cancer Res 63 (2003) 3560-3566
34. Theodoropoulos G., Papaconstantinou I., Felekouras E., et al. Relation between common polymorphisms in genes related to inflammatory response and colorectal cancer. World J Gastroenterol 12 (2006) 5037-5043
35. Wilkening S., Tavelin B., Canzian F., et al. Interleukin promoter polymorphisms and prognosis in colorectal cancer. Carcinogenesis 29 (2008) 1202-1206
36. Vogel U., Christensen J., Dybdahl M., et al. Prospective study of interaction between alcohol, NSAID use and polymorphisms in genes involved in the inflammatory response in relation to risk of colorectal cancer. Mutat Res 624 (2007) 88-100
37. Cacev T., Radosevic S., Krizanac S., and Kapitanovic S. Influence of interleukin-8 and interleukin-10 on sporadic colon cancer development and progression. Carcinogenesis 29 (2008) 1572-1580
38. McCarron S.L., Edwards S., Evans P.R., et al. Influence of cytokine gene polymorphisms on the development of prostate cancer. Cancer Res 62 (2002) 3369-3372
39. Michaud D.S., Daugherty S.E., Berndt S.I., et al. Genetic polymorphisms of interleukin-1B (IL-1B), IL-6, IL-8, and IL-10 and risk of prostate cancer. Cancer Res 66 (2006) 4525-4530
40. Wang M.H., Helzlsouer K.J., Smith M.W., et al. Association of IL10 and other immune response- and obesity-related genes with prostate cancer in CLUE II. Prostate 69 (2009) 874-885
41. Yang H.P., Woodson K., Taylor P.R., et al. Genetic variation in interleukin 8 and its receptor genes and its influence on the risk and prognosis of prostate cancer among Finnish men in a large cancer prevention trial. Eur J Cancer Prev 15 (2006) 249-253
42. Campa D., Zienolddiny S., Maggini V., et al. Association of a common polymorphism in the cyclooxygenase 2 gene with risk of non-small cell lung cancer. Carcinogenesis 25 (2004) 229-235
43. Campa D., Hung R.J., Mates D., et al. Lack of association between -251 T>A polymorphism of IL8 and lung cancer risk. Cancer Epidemiol Biomarkers Prev 14 (2005) 2457-2458
44. Lee K.M., Shen M., Chapman R.S., et al. Polymorphisms in immunoregulatory genes, smoky coal exposure and lung cancer risk in Xuan Wei, China. Carcinogenesis 28 (2007) 1437-1441
45. Vogel U., Christensen J., Wallin H., et al. Polymorphisms in genes involved in the inflammatory response and interaction with NSAID use or smoking in relation to lung cancer risk in a prospective study. Mutat Res 639 (2008) 89-100
46. Ben Nasr H., Chahed K., Mestiri S., et al. Association of IL-8 (-251)T/A polymorphism with susceptibility to and aggressiveness of nasopharyngeal carcinoma. Hum Immunol 68 (2007) 761-769
47. Wei Y.S., Lan Y., Tang R.G., et al. Single nucleotide polymorphism and haplotype association of the interleukin-8 gene with nasopharyngeal carcinoma. Clin Immunol 125 (2007) 309-317
48. Tai S.H., Wei Y.S., Wang P., et al. Genetic polymorphisms of interferon-gamma and interleukin-8 in patients with nasopharyngeal carcinoma. Sichuan Da Xue Xue Bao Yi Xue Ban 38 (2007) 862-865
49. Leibovici D., Grossman H.B., Dinney C.P., et al. Polymorphisms in inflammation genes and bladder cancer: from initiation to recurrence, progression, and survival. J Clin Oncol 23 (2005) 5746-5756
50. Shimizu Y., Kondo S., Shirai A., Furukawa M., and Yoshizaki T. A single nucleotide polymorphism in the matrix metalloproteinase-1 and interleukin-8 gene promoter predicts poor prognosis in tongue cancer. Auris Nasus Larynx 35 (2008) 381-389
51. Vogel U., Christensen J., Wallin H., et al. Polymorphisms in COX-2, NSAID use and risk of basal cell carcinoma in a prospective study of Danes. Mutat Res 617 (2007) 138-146
52. Vairaktaris E., Yapijakis C., Serefoglou Z., et al. Gene expression polymorphisms of interleukins-1 beta, -4, -6, -8, -10, and tumor necrosis factors-alpha, -beta: regression analysis of their effect upon oral squamous cell carcinoma. J Cancer Res Clin Oncol 134 (2008) 821-832
53. Zhang L.W., Du C.Q., Niu W.W., et al. Association of an interleukin-8 promoter polymorphism with esophageal squamous cell carcinoma in the taihang mountain region. Chin J Clin Oncol 35 (2008) 591-595
54. Howell W.M., Turner S.J., Theaker J.M., and Bateman A.C. Cytokine gene single nucleotide polymorphisms and susceptibility to and prognosis in cutaneous malignant melanoma. Eur J Immunogenet 30 (2003) 409-414
55. van der Kuyl A.C., Polstra A.M., Weverling G.J., et al. An IL-8 gene promoter polymorphism is associated with the risk of the development of AIDS-related Kaposi's sarcoma: a case-control study. AIDS 18 (2004) 1206-1208
56. Lu Y., Wang Z.D., Shen J., and Xu Y.C. Meta-analysis on the relationship between IL8 -251 gene polymorphism and gastric cancer. Zhonghua Yu Fang Yi Xue Za Zhi 41 Suppl. (2007) 39-42
57. Vairaktaris E., Yapijakis C., Serefoglou Z., et al. The interleukin-8 (-251A/T) polymorphism is associated with increased risk for oral squamous cell carcinoma. Eur J Surg Oncol 33 (2007) 504-507
58. Higgins J.P., and Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat Med 21 (2002) 1539-1558
59. Mantel N., and Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22 (1959) 719-748
60. DerSimonian R., and Laird N. Meta-analysis in clinical trials. Control Clin Trials 7 (1986) 177-188
61. Egger M., Davey Smith G., Schneider M., and Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 315 (1997) 629-634
62. Sipponen P., Kosunen T.U., Valle J., Riihela M., and Seppala K. Helicobacter pylori infection and chronic gastritis in gastric cancer. J Clin Pathol 45 (1992) 319-323
63. Saxena A., Nath Prasad K., Chand Ghoshal U., et al. Association of Helicobacter pylori and Epstein-Barr virus with gastric cancer and peptic ulcer disease. Scand J Gastroenterol 43 (2008) 669-674
64. Shimoyama T., Everett S.M., Fukuda S., et al. Influence of smoking and alcohol on gastric chemokine mRNA expression in patients with Helicobacter pylori infection. J Clin Pathol 54 (2001) 332-334
65. Hecht S.S. Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention. Lancet Oncol 3 (2002) 461-469
66. You W.C., Blot W.J., Chang Y.S., et al. Diet and high risk of stomach cancer in Shandong, China. Cancer Res 48 (1988) 3518-3523
67. Campa D., Hashibe M., Zaridze D., et al. Association of common polymorphisms in inflammatory genes with risk of developing cancers of the upper aerodigestive tract. Cancer Causes Control 18 (2007) 449-455